These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38102539)

  • 1. Better performance for right-skewed data using an alternative gamma model.
    Veazie P; Intrator O; Kinosian B; Phibbs CS
    BMC Med Res Methodol; 2023 Dec; 23(1):298. PubMed ID: 38102539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of statistical models to predict mental health and substance abuse cost.
    Montez-Rath M; Christiansen CL; Ettner SL; Loveland S; Rosen AK
    BMC Med Res Methodol; 2006 Oct; 6():53. PubMed ID: 17067394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of statistical estimators for risk-adjusted length of stay: analysis of the Australian and new Zealand Intensive Care Adult Patient Data-Base, 2008-2009.
    Moran JL; Solomon PJ;
    BMC Med Res Methodol; 2012 May; 12():68. PubMed ID: 22591115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of several methods for analyzing censored data.
    Hewett P; Ganser GH
    Ann Occup Hyg; 2007 Oct; 51(7):611-32. PubMed ID: 17940277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical models for the analysis of skewed healthcare cost data: a simulation study.
    Malehi AS; Pourmotahari F; Angali KA
    Health Econ Rev; 2015; 5():11. PubMed ID: 26029491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the mean and standard deviation of environmental data with below detection limit observations: Considering highly skewed data and model misspecification.
    Shoari N; Dubé JS; Chenouri S
    Chemosphere; 2015 Nov; 138():599-608. PubMed ID: 26210025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of statistical and machine learning models for healthcare cost data: a simulation study motivated by Oncology Care Model (OCM) data.
    Mazumdar M; Lin JJ; Zhang W; Li L; Liu M; Dharmarajan K; Sanderson M; Isola L; Hu L
    BMC Health Serv Res; 2020 Apr; 20(1):350. PubMed ID: 32334595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Ridge-Type Estimator for the Gamma Regression Model.
    Lukman AF; Dawoud I; Kibria BMG; Algamal ZY; Aladeitan B
    Scientifica (Cairo); 2021; 2021():5545356. PubMed ID: 34249382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A targeted maximum likelihood estimator of a causal effect on a bounded continuous outcome.
    Gruber S; van der Laan MJ
    Int J Biostat; 2010; 6(1):Article 26. PubMed ID: 21731529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Improved Parameter Estimator of the Homodyned K Distribution Based on the Maximum Likelihood Method for Ultrasound Tissue Characterization.
    Liu Y; Zhang Y; He B; Li Z; Lang X; Liang H; Chen J
    Ultrason Imaging; 2022 Jul; 44(4):142-160. PubMed ID: 35674146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Random-effects, fixed-effects and the within-between specification for clustered data in observational health studies: a simulation study.
    Dieleman JL; Templin T
    PLoS One; 2014; 9(10):e110257. PubMed ID: 25343620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative double robust targeted maximum likelihood estimation.
    van der Laan MJ; Gruber S
    Int J Biostat; 2010 May; 6(1):Article 17. PubMed ID: 20628637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating overdispersion in sparse multinomial data.
    Afroz F; Parry M; Fletcher D
    Biometrics; 2020 Sep; 76(3):834-842. PubMed ID: 31785150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating incremental costs with skew: a cautionary note.
    Polgreen LA; Brooks JM
    Appl Health Econ Health Policy; 2012 Sep; 10(5):319-29. PubMed ID: 22762544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized modeling approaches to risk adjustment of skewed outcomes data.
    Manning WG; Basu A; Mullahy J
    J Health Econ; 2005 May; 24(3):465-88. PubMed ID: 15811539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequentist and Bayesian tolerance intervals for setting specification limits for left-censored gamma distributed drug quality attributes.
    Montes RO
    Pharm Stat; 2024; 23(2):168-184. PubMed ID: 37871968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative assessment of parameter estimation methods in the presence of overdispersion: a simulation study.
    Roosa K; Luo R; Chowell G
    Math Biosci Eng; 2019 May; 16(5):4299-4313. PubMed ID: 31499663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing continuous non-normal skewed distributions in latent growth mixture modeling: An assessment of specification errors and class enumeration.
    Depaoli S; Winter SD; Lai K; Guerra-Peña K
    Multivariate Behav Res; 2019; 54(6):795-821. PubMed ID: 31012738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.